NOVO-B.CO vs. SAABY

Last updated Jun 5, 2026

NOVO-B.CO (Novo Nordisk A/S) and SAABY (Saab AB (publ)) are both stocks. NOVO-B.CO operates in Biotechnology (Healthcare), while SAABY operates in Aerospace & Defense (Industrials). Over the past 5 years, NOVO-B.CO returned 5.13%/yr vs 52.52%/yr for SAABY. At a 0.03 correlation, their price movements are largely independent.

Performance

NOVO-B.CO vs. SAABY - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in Novo Nordisk A/S (NOVO-B.CO) and Saab AB (publ) (SAABY). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

NOVO-B.CO is traded in DKK, while SAABY is traded in USD. To make them comparable, the SAABY values have been converted to DKK using the latest available exchange rates.

Returns By Period

In the year-to-date period, NOVO-B.CO achieves a -9.72% return, which is significantly lower than SAABY's -2.68% return.

NOVO-B.CO

• 1D: 4.43%
• 1M: -3.12%
• YTD: -9.72%
• 6M: -5.16%
• 1Y: -37.68%
• 3Y*: -17.20%
• 5Y*: 5.13%
• 10Y*: 6.71%

SAABY

• 1D: -1.03%
• 1M: -11.47%
• YTD: -2.68%
• 6M: 7.30%
• 1Y: 3.44%
• 3Y*: 53.61%
• 5Y*: 52.52%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

NOVO-B.CO vs. SAABY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
NOVO-B.CO Novo Nordisk A/S	-9.72%	-46.40%	-9.59%	50.74%	29.53%	75.62%	4.74%
SAABY Saab AB (publ)	-2.68%	145.05%	49.15%	43.02%	77.71%	-45.04%	62.55%

Correlation

The correlation between NOVO-B.CO and SAABY is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.08
Correlation (3Y) Calculated over the trailing 3-year period	0.08
Correlation (5Y) Calculated over the trailing 5-year period	0.04
Correlation (All Time) Calculated using the full available price history since Apr 16, 2020	0.03

Return for Risk

NOVO-B.CO vs. SAABY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NOVO-B.CO

NOVO-B.CO Risk / Return Rank: 16
NOVO-B.CO Sharpe Ratio Rank: 12
NOVO-B.CO Sortino Ratio Rank: 15
NOVO-B.CO Omega Ratio Rank: 14
NOVO-B.CO Calmar Ratio Rank: 16
NOVO-B.CO Martin Ratio Rank: 21

SAABY

SAABY Risk / Return Rank: 43
SAABY Sharpe Ratio Rank: 44
SAABY Sortino Ratio Rank: 42
SAABY Omega Ratio Rank: 41
SAABY Calmar Ratio Rank: 44
SAABY Martin Ratio Rank: 45

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NOVO-B.CO vs. SAABY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and Saab AB (publ) (SAABY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NOVO-B.CO	SAABY	Difference
Sharpe ratio: Return per unit of total volatility	-0.70	0.07	-0.77
Sortino ratio: Return per unit of downside risk	-0.75	0.46	-1.20
Omega ratio: Gain probability vs. loss probability	0.89	1.05	-0.16
Calmar ratio: Return relative to maximum drawdown	-0.69	0.10	-0.79
Martin ratio: Return relative to average drawdown	-1.03	0.25	-1.28
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NOVO-B.CO vs. SAABY - Sharpe Ratio Comparison

The current NOVO-B.CO Sharpe Ratio is -0.70, which is lower than the SAABY Sharpe Ratio of 0.07. The chart below compares the historical Sharpe Ratios of NOVO-B.CO and SAABY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NOVO-B.CO	SAABY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.70	0.07	-0.77
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.13	1.13	-0.99
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.21	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.53	0.74	-0.22

Drawdowns

NOVO-B.CO vs. SAABY - Drawdown Comparison

The maximum NOVO-B.CO drawdown since its inception was -76.75%, which is greater than SAABY's maximum drawdown of -51.50%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and SAABY.

Drawdown Indicators

	NOVO-B.CO	SAABY	Difference
Max Drawdown Largest peak-to-trough decline	-76.75%	-51.50%	-25.25%
Max Drawdown (1Y) Largest decline over 1 year	-54.94%	-35.46%	-19.48%
Max Drawdown (3Y) Largest decline over 3 years	-76.75%	-35.46%	-41.29%
Max Drawdown (5Y) Largest decline over 5 years	-76.75%	-35.46%	-41.29%
Max Drawdown (10Y) Largest decline over 10 years	-76.75%	—	—
Current Drawdown Current decline from peak	-70.51%	-29.58%	-40.93%
Average Drawdown Average peak-to-trough decline	-16.01%	-16.18%	+0.17%
Ulcer Index Depth and duration of drawdowns from previous peaks	36.70%	13.60%	+23.10%

Volatility

NOVO-B.CO vs. SAABY - Volatility Comparison

The current volatility for Novo Nordisk A/S (NOVO-B.CO) is 9.89%, while Saab AB (publ) (SAABY) has a volatility of 15.74%. This indicates that NOVO-B.CO experiences smaller price fluctuations and is considered to be less risky than SAABY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NOVO-B.CO	SAABY	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.89%	15.74%	-5.85%
Volatility (6M) Calculated over the trailing 6-month period	39.23%	31.80%	+7.43%
Volatility (1Y) Calculated over the trailing 1-year period	54.38%	48.61%	+5.77%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	38.71%	46.82%	-8.11%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.58%	57.48%	-24.90%

Dividends

NOVO-B.CO vs. SAABY - Dividend Comparison

NOVO-B.CO's dividend yield for the trailing twelve months is around 4.12%, more than SAABY's 0.43% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NOVO-B.CO Novo Nordisk A/S	4.12%	3.58%	1.59%	1.01%	1.19%	1.27%	2.02%	2.11%	2.64%	2.27%	3.69%	1.25%
SAABY Saab AB (publ)	0.43%	0.36%	0.73%	0.84%	1.24%	2.19%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both NOVO-B.CO and SAABY in my portfolio?

NOVO-B.CO and SAABY have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.